Regeneron Pharmaceuticals (NASDAQ:REGN) Rating Lowered to “Hold” at StockNews.com
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday. Several other equities analysts also recently weighed in on REGN. The Goldman Sachs Group reduced their target price on shares of Regeneron Pharmaceuticals from […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday. Several other equities analysts also recently weighed in on REGN. The Goldman Sachs Group reduced their target price on shares of Regeneron Pharmaceuticals from […]
